CClinicalTrials.gg
TerminatedNCT02903303Updated Aug 23, 2021

Hypnosis as a Potentiation Technique for the Interventional Treatment of Chronic Lumbar Pain

An interventional study of Hypnosis in Chronic Pain, sponsored by Centre Hospitalier Universitaire Vaudois. Terminated at 1 site in Switzerland. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-08-23.

Sponsored by Centre Hospitalier Universitaire Vaudois · Not applicable, Interventional, and Treatment

Why this study was terminated
end of recruitment period
Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This pilot study consists in testing the efficacy of hypnosis as an adjuvant treatment for patients suffering from chronic lumbar pain and for whom a facet block is indicated by a doctor in the Centre d'antalgie of CHUV (Centre Hospitalier Universitaire Vaudois), where this study will take place. 5 to 8 patients will be included in this study. The goals of this study are :

  • Assess the feasibility of such a protocol with more patients
  • Measure the number of patients necessary to obtain a significant result
  • Search for possible side effects of the combination of both treatments

Every patient in this pilot study will undergo 4 hypnosis sessions within 2 weeks before the facet block. These sessions will be done with an hypnotherapist formed for this kind of treatment.

Three times during this study, each patient will have a discussion with the co-investigator :¨

  • 1st discussion : just before the first hypnosis session
  • 2nd discussion : after the 4 hypnosis sessions and just before the facet block, approximately 3 to 4 weeks after the 1st discussion
  • 3rd discussion : 2 to 4 weeks after the facet block

They will allow to obtain several data :

  • Pain assessment : intensity, localization, variability, characteristics, effects on daily life activities
  • Anxiety and depression assessment
  • Expectations assessment : about both treatments and their combination
  • Efficacy assessment : about both treatments for the patient
  • Questions about the perceptions of the treatments (prejudice, ...) et possible side effects.

These data will then be analysed (quantitative and qualitative analysis, depending on the question type) to fulfill the objectives of the study.

will include 5 to 8 people suffering from chronic lumbar pain. The procedure consists in two steps :

  1. 4 hypnosis sessions as an adjuvant treatment for number 2
  2. a facet block, which is the standard procedure in the Centre d'antalgie in CHUV.

There will be no control group, so every patient will participate to the hypnosis sessions and undergo the facet block. All the procedure of the facet block (including contraindications and side effects) are not considered to be part of this study because all patients in this study would have had a facet block if they would not participate in it.

The only data that will be collected are questionnaires about several items (pain, anxiety, depression, ...). These questionnaires are filled with the patient at the beginning of the study (day 0), before the facet block (between day 14 and day 21) and 2-4 weeks after it (between day 28 and day 49). There are quantitative and qualitative questions.

02

Conditions studied

  • Chronic Pain

Browse trials for

03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's enrollment of 3 is below the median of 60 across 2,161 interventional studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Centre Hospitalier Universitaire Vaudois is the lead sponsor of 203 studies on the registry; 47 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Informed consent and signature of the declaration of consent ;
  • Patient suffering from chronic lumbar pain (> 3 months)
  • Indication for a facet block ;
  • Good ability to speak and understand French.

Exclusion criteria

Exclusion Criteria:

  • Previous facet block for the same indication ;
  • Unability to understand or speak French ;
  • Unability to understand the written or oral instructions necessary to the protocol application ;
  • Acute or severe psychiatric decompensation and/or acute psychosocial distress ;
  • Complex psychosocial situation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
3 participants (actual)

Study arms

  • Other
    Treatment

    There will be only one arm for this pilot study. All participants will follow 4 hypnosis sessions, and then the facet block.

    Other: Hypnosis

Interventions

  • OtherHypnosis

    It will consist in 4 hypnosis sessions within 2 weeks mainly for analgesic purpose. The main themes are : * 1st session : contact with the therapist, body scan, basic suggestions * 2nd session : hypnosis induction followed by suggestions tu build a safe place * 3rd session : it is the first complete hypnosis session (induction and specific suggestions against pain) * 4th session : very similar to the previous session for the content, focused on auto-hypnosis learning.

06

What researchers measure

Primary outcomes

  1. Daily pain history

    During the first encounter (day 0), we will ask the patient since when he/she suffers from daily pain: * Daily pain in general since : \< 3 months ; 3-6 months ; 6-12 months ; 1-3 years ; 3-5 years ; 5-10 years ; 10-20 years ; \> 20 years * Daily lumbar pain since : \< 6 months ; 6-12 months ; 1-3 years ; \> 3 years

    Time frame: 1st encounter with the co-investigator (day 0)

  2. Change in pain localization

    For this outcome, the patient is asked to say where is the daily pain and to precise if the pain concerns both sides. If there is more than one localization, the patient is asked to say which pain is the worst for him/her.

    Time frame: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  3. Change in neuropathic characteristics of the lumbar pain

    Neuropathic characteristics (yes/no) : * burning * painful cold * electricity sensation * swarming * tingle * itching * numbness

    Time frame: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  4. Change in lumbar pain intensity

    Intensity on a scale from 0 (no pain) to 10 (worst pain imaginable) : * Worst pain during the previous week * Lowest pain during the previous week * Average pain during the previous week

    Time frame: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  5. Change in lumbar pain interferences

    For this outcome, we will ask the patient to tell us how much between 0 (no influence at all) and 10 (complete discomfort) the lumbar pain has on : A) General activity B) Mood C) Ability to walk D) Usual work E) Relationship with others F) Sleep G) Taste of living

    Time frame: 1st, 2nd and 3rd encounters with the co-investigator (day 0, day 14-21, day 28-49)

  6. Change in Anxiety and Depression assessment

    In this pilot study, we will use the HADS scale (Hospital Anxiety and Depression Scale) to assess the level of anxiety and depression at the beginning of the study (day 0) and at the end of it (day 28-49). The items are the following (on a scale from 0 to 3, depending on the agreement to the sentence) : 1. I feel tense and angry 2. I am afraid, just like if something horrible was going to happen to me 3. I'm worried 4. I can sit quietly doing nothing and feel relaxed 5. I experience feelings of fear and feel my stomach tensed 6. I have ants in my pants and can't stay in place 7. I experience sudden feelings of panic 8. I feel the same pleasure to the same things as before 9. I easily laugh and see things in a good way 10. I am in a good mood 11. I feel like I work slowly 12. I don't take care about my appearance anymore 13. I'm looking forward to doing some things 14. I can enjoy a good book or a good TV/radio show

    Time frame: 1st and 3rd encounters with the co-investigator (day 0, day 28-49)

  7. Presumed efficacy and expectations about treatments of lumbar pain

    On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the presumed efficacy in general of : (only for the 1st encounter) 1. Hypnosis alone 2. Facet block alone 3. Combination of both On a scale from 0 to 10, the patient assesses the expectations towards 1), 2) and 3).

    Time frame: 1st encounter (day 0)

  8. Efficacy about treatments of lumbar pain

    On a scale from 0 (no efficacy at all) to 10 (completely relieves the pain), the patient assesses the efficacy of : 1. Hypnosis alone 2. Facet block alone 3. Combination of both

    Time frame: 3rd encounter (day 28-49)

  9. Functionality enhancement expectations thanks to hypnosis

    On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much he/she thinks hypnosis will enhance the ability to : 1. do sports 2. practice the professional activity 3. do your daily activities 4. enhance your mood 5. other (free space for the patient to write)

    Time frame: 1st encounter (day 0)

  10. Functionality enhancement thanks to hypnosis

    On a scale from 1 (minimal impact) to 5 (maximal enhancement), the patient assesses how much hypnosis has enhanced his/her ability to : 1. do sports 2. practice the professional activity 3. do your daily activities 4. enhance your mood 5. other (same item as in outcome 9)

    Time frame: 3rd encounter (day 28-40)

  11. Questions with a qualitative analysis (part 1)

    During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following : * How do you think hypnosis work ? * What do you think will happen during hypnosis ? * Does it make you experience any emotions ? * What do you think of hypnosis as a therapeutical approach ? * How do you think facet block works ? * What do you think will happen during this intervention ? * What do you think of facet block as a therapeutical approach ? * What is your position about pain-relief drugs ? * Do you use other approaches against pain ? If yes, which one and what does and doesn't work with you ? * Do you have further comments about both treatments ?

    Time frame: 1st encounter (day 0)

  12. Questions with a qualitative analysis (part 2)

    During this encounter, we will ask questions to the patient and write down the main subjects mentioned, so that a theme-based analysis can be done with these. The questions are the following : * How do you feel now about hypnosis as a treatment against pain ? * Did your mind change about hypnosis ? If yes, how and in what ? * Now, do you consider using hypnosis and/or self-hypnosis as a new way to deal with your lumbar pain ? * Do you have further comments about the study or the procedure ?

    Time frame: 3rd encounter (day 28-49)

Secondary outcomes

  1. Security assessment

    Immediately after the beginning of the study, every patient will be told to report every adverse effect or discomfort during or after an hypnosis session. During the hypnosis session, the therapist will be vigilant about possible negative effects and will help the patient go through it. He will also make a report about it. Every adverse effect will be discussed in detail with the patient during the 2nd or the 3rd discussion with the co-investigator.

    Time frame: 2nd and 3rd encounters (day 14-21, day 24-49)

07

Study locations

1 site
  • Centre d'antalgie, Centre Hospitalier Universitaire Vaudois
    Lausanne, Vaud 1011, Switzerland
08

References and documents

Individual participant data

Plan to share: No — Participant data will remain accessible only for the people working in this study. However, the results will be shown in the context of a master degree in medicine of Mr Florent Schroeter.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 23, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02903303
Lead sponsor
Centre Hospitalier Universitaire Vaudois
Responsible party
Marc R Suter (PD Doctor, Centre Hospitalier Universitaire Vaudois) — Principal investigator
First posted
Sep 16, 2016
Start date
Jun 1, 2016
Primary completion
Sep 1, 2016
Completion
Sep 1, 2016
Last update
Aug 23, 2021

Study contacts

Marc Suter, Doctor, PD
principal investigator · Centre Hospitalier Universitaire Vaudois

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion